Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Viral Hepatitis and Liver Diseases in Mongolia.
Baatarkhuu O, Uugantsetseg G, Munkh-Orshikh D, Naranzul N, Badamjav S, Tserendagva D, Amarsanaa J, Do Young K. Baatarkhuu O, et al. Euroasian J Hepatogastroenterol. 2017 Jan-Jun;7(1):68-72. doi: 10.5005/jp-journals-10018-1215. Epub 2017 May 5. Euroasian J Hepatogastroenterol. 2017. PMID: 29201776 Free PMC article. Review.
The most common etiology for hepatocellular carcinoma was HCV infection (n = 89, 45.6%), followed by HBV infection (n = 67, 34.4%). How to cite this article: Baatarkhuu O, Uugantsetseg G, Munkh-Orshikh D, Naranzul N, Badamjav S, Tserendagva D, Amarsanaa J, Young KD. …
The most common etiology for hepatocellular carcinoma was HCV infection (n = 89, 45.6%), followed by HBV infection (n = 67, 34.4%). How to c …
Epidemiology, Genotype Distribution, Prognosis, Control, and Management of Viral Hepatitis B, C, D, and Hepatocellular Carcinoma in Mongolia.
Baatarkhuu O, Gerelchimeg T, Munkh-Orshikh D, Batsukh B, Sarangua G, Amarsanaa J. Baatarkhuu O, et al. Euroasian J Hepatogastroenterol. 2018 Jan-Jun;8(1):57-62. doi: 10.5005/jp-journals-10018-1260. Epub 2018 May 1. Euroasian J Hepatogastroenterol. 2018. PMID: 29963464 Free PMC article. Review.
Consequently, access to antiviral therapies is now improving in Mongolia. How to cite this article: Baatarkhuu O, Gerelchimeg T, Munkh-Orshikh D, Batsukh B, Sarangua G, Amarsanaa J. ...
Consequently, access to antiviral therapies is now improving in Mongolia. How to cite this article: Baatarkhuu O, Gerelchimeg …
Resistance-associated substitution and ledipasvir/sofosbuvir therapy in Mongolian chronic hepatitis C patients.
Hsu SJ, Enkhzaya S, Lin YY, Tseng TC, Khosbayar T, Tsai CH, Wang TS, Enkhtuya D, Ivshinkhorol D, Naranzul N, Jargalsaikhan B, Amarsanaa J, Baatarkhuu O, Kao JH. Hsu SJ, et al. Among authors: baatarkhuu o. J Formos Med Assoc. 2020 Mar;119(3):712-719. doi: 10.1016/j.jfma.2019.10.003. Epub 2019 Oct 28. J Formos Med Assoc. 2020. PMID: 31672433 Free article.
Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study.
Baatarkhuu O, Lee JS, Amarsanaa J, Kim DY, Ahn SH, Naranzul N, Enkhtuya D, Choijamts N, Batbayar P, Otgonbayar R, Saruul BU, Gantuul C, Gegeebadrakh B, Tuvshinbayar N, Badamsuren D, Ulzmaa G, Otgonbold J, Han KH. Baatarkhuu O, et al. Clin Mol Hepatol. 2021 Jan;27(1):125-135. doi: 10.3350/cmh.2020.0023. Epub 2020 Nov 27. Clin Mol Hepatol. 2021. PMID: 33242929 Free PMC article.
39 results